Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EOC Gears To Evolve Into Integrated Oncology Company

Nov 30 2017

• By Ying Huang

Xiaoming Zou, EOC Pharma CEO — CEO Xiaoming ZOU • Source: EOC Pharma

Related Content

Entinostat deal expands Eddingpharm's China oncology portfolio

Sep 05 2013

Eddingpharm JV Gives Faes Smoother Route Into China

Jun 16 2015

China’s Eddingpharm Deal A Fresh Start For Ablynx’s Ozoralizumab

Sep 08 2014

Eddingpharm acquires most ACT assets including telatinib

Jan 10 2014

Flying High: China’s Eddingpharm Takes Another Step With Its First Global Licensing Deal

Jan 10 2014

Related Companies

Eddingpharm

Syndax Pharmaceuticals, Inc.

ACT Biotech, Inc.

Ablynx N.V.

Amarin Corp plc

Cardiome Pharma Corp.

ALK Laboratorierne AS

Immutep Ltd.

Orphan Disease Treatment Institute Co., Ltd.

Pharmacosmos A/S

Chiesi Farmaceutici S.p.A.

Faes Farma, S.A.

Additional Topics

China Asia Pacific Commercial Strategy BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window